维普期刊资源整合服务平台（V6.5）

21篇 您的检索式：作者名="TSIMBERIDOU A M"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia显示文摘	TSIMBERIDOU A M KANTARJIAN H W WEN S	2008	Cancer2008，113，：	1
2	Activity of interferon - alpha and isotretionoin in patients with advanced, refractor lymphoid malignancies 显示文摘	TSIMBERIDOU A M GILES F ROMAGUERA J	2004	Cancer2004，100，4：	1
3	Dasatinib in chronic myeloid leukemia: a review显示文摘	Aguilera D G Tsimberidou A M	2009	Ther Clin Risk Manag2009，5，：	1
4	Extramedullary relapse in a patient with acute promyelocytic leukemia:successful treatment with arsenic trioxide, all-trans retinoic acid and gemtuzumab ozogamicin therapies显示文摘	TSIMBERIDOU A M ESTEY E WHITMAN G J	2004	Leuk Res2004，28，：	1
5	TNF-alpha targeted therapeutic approaches in patients with hematologic malignancies显示文摘	TSIMBERIDOU A M GILES F J	2002	Expert Rev Anticancer Ther2002，2，3：	1
6	Potential curability of newly diagnosed acute promyelocytic leukemia without use of chemotherapy:the example of liposomal all-trans retinoic acid显示文摘	Estey E Koller C Tsimberidou A M	2005	Blood2005，105，3：	1
7	PIK3CA Mutations in Patients with Advanced Cancers Treated with PI3K/AKT/mTOR Axis Inhibitor 显示文摘	Janku F Tsimberidou A M Garrido-Laguna I	2011	Mol Cancer Ther2011，10，3：	1
8	Phase Ⅱ study of fludarabine,cytarabine (Ara-C),cyclophosphamide,cisplatin and GM-CSF (FACPGM) in patients with Richter's syndrome or refractory lymphoproliferative disorders显示文摘	Tsimberidou A M O'Brien S M Cortes J E	2002	Leuk Lymphoma2002，43，4：	1
9	Antibody-independent isolation of circulating tumor cells by continuous-flow dielectrophoresis显示文摘	Shim S Stemke-Hale K Tsimberidou A M	2013	Biomicrofluidics2013，7，11：	1
10	Antibody-independent isolation of circulating tumor cells by continuous-flow dielectrophoresis显示文摘	Shim S Stemke-Hale K Tsimberidou A M	2013	Biomicrofluidics2013，7，11：	1
11	Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy显示文摘	TSIMBERIDOU A M KANTARIIAN H M ESTEY E	2003	Leukemia2003，17，：	1
12	Personalized Medicine in a Phase I Clinical Trials Program: The M D Anderson Cancer Center Initiative显示文摘	Tsimberidou A M Iskander N G Hang D S	2012	Clin Cancer Res2012，，：	1
13	Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug rdsistance protein and lung resistance protein in patients with primary acute myelogenous leukemia显示文摘	TSIMBERIDOU A M PATERAKIS G ANDROUTSOS G	2002	Leukiemia research2002，26，2：	1
14	The prognostic significance of serum beta2 microglobulin levels in acute myeloid leukemia and prognostic scores predicting survival:analysis of 1, 180 patients显示文摘	TSIMBERIDOU A M KANTARJIAN H M WEN S	2008	Clin Cancer Res2008，14，：	1
15	TNF-A targeted therapeutic in patients with hematologic malignancies显示文摘	TSIMBERIDOU A M GILEES F J	2002	Expert Rev Anticancer Ther2002，2，：	1
16	Potential curability of newly diagnosed acute promyelocytic leukemia without use of chemotherapy : the example of liposomal all-trans retinoic acid 显示文摘	Estey E Koller C Tsimberidou A M	2005	Blood2005，105，3：	1
17	Detection of Richter' s transformation of chronic lymphocytic leukemia by PET/CT显示文摘	Bruzzi J F Macapinlac H Tsimberidou A M	2006	J Nucl Med2006，47，8：	1
18	Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy显示文摘	Tsimberidou A M Kantarjian H M Estey E	2003	Leukemia2003，17，6：	1
19	Chemoimmunotherapy may overcome the adverse prognostic significance of 11q deletion in previously untreated patients with chronic lymphocytic leukemia显示文摘	TSIMBERIDOU A M TAM C ABRUZZO LV	2009	Cancer2009，115，2：	1
20	Outcome in patients with nonleukemic granulocyticsarcoma treated with chemotherapy with or withoutradiotherapy显示文摘	TSIMBERIDOU A M KANTARJIAN H M ESTEYE	2003	Leukemia2003，17，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示